Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05433090 · ClinicalTrials.gov registry record · NA
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05433090: Completed NA study, sponsored by University of Rochester.
NCT05433090 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05433090, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies
Primary Outcome
Retention rate is the percentage of consented patients who completed the ACP intervention visit. A retention rate of \>70% was considered feasible.
Interventions
- BEHAVIORAL Inpatient serious illness care program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-11-23 |
| Est. Completion | 2024-11-14 |
| Phase | NA |
What the finished NCT05433090 record still lists
NCT05433090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Inpatient serious illness care program is the first listed.
NCT05433090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05433090 about?
NCT05433090 is a clinical study titled "An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies". This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies
What is the current status of trial NCT05433090?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2022-11-23. Estimated completion is 2024-11-14.
What interventions are being tested in trial NCT05433090?
The interventions under investigation include: Inpatient serious illness care program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05433090?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05433090's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI